Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Advance ZincTek Limited ( (AU:ANO) ).
Advance ZincTek Limited has received feedback from the U.S. Food and Drug Administration (FDA) following a routine inspection, highlighting several compliance issues related to Good Manufacturing Practice (GMP). These issues pertain to supplier qualification, precursor handling processes, and digital record-keeping systems, among others. The company has stated that there is no impact on the supply to U.S. customers and no concerns about product quality. In response, Advance ZincTek plans to engage U.S. regulatory consultants to ensure alignment with FDA requirements, provide additional GMP training, and increase investment in compliance efforts. The company is committed to resolving all outstanding observations and will keep stakeholders informed of any significant developments.
The most recent analyst rating on (AU:ANO) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Advance ZincTek Limited stock, see the AU:ANO Stock Forecast page.
More about Advance ZincTek Limited
Average Trading Volume: 6,093
Technical Sentiment Signal: Hold
Current Market Cap: A$74.86M
See more insights into ANO stock on TipRanks’ Stock Analysis page.